Skip to main content

Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?

Buy Article:

$43.00 + tax (Refund Policy)

Treatment of injecting drug users (IDU) for hepatitis C virus (HCV) infection may prevent onward transmission. Treating individuals who often share injecting equipment is most likely to prevent new infections. However, these high‐risk IDU are also more likely to become re‐infected than low‐risk IDU. We investigated to which group treatment is best targeted.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: HCV; HCV prevention; injecting drug use; mathematical modelling; risk heterogeneity; treatment as prevention

Document Type: Research Article

Publication date: 01 June 2015

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more